Novartis Gene Therapies Global Managed Access Program
Novartis Gene Therapies recommits to Global Managed Access Program for 2021 so that children around the world can benefit from SMA treatment who otherwise would not have access to Zolgensma.
Novartis announced the company’s financial results for the third quarter of 2021.
Our research redefines the way we understand disease and develop medicines. Discover the people and stories that make it possible.
The Annual Review explains who we are and what we do, and highlights our progress against the company’s five strategic priorities in 2020.
Novartis aims to hold itself to the highest standards of sustainability and ethical business practices.
Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.
Live is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the company.